SAN DIEGO (AP) _ Neurocrine Biosciences Inc. (NBIX) on Wednesday reported first-quarter profit of $32.1 million.

On a per-share basis, the San Diego-based company said it had net income of 33 cents.

The results missed Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was for earnings of 47 cents per share.

The biopharmaceutical company posted revenue of $236.6 million in the period, which also fell short of Street forecasts. Ten analysts surveyed by Zacks expected $247.8 million.

Neurocrine shares have fallen 4.5% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $91.51, a fall of 10% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NBIX at https://www.zacks.com/ap/NBIX